A Study of Intensive-Dose Melphalan, Topotecan, and VP-16 Phosphate (MTV) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2018
At a glance
- Drugs Etoposide phosphate (Primary) ; Melphalan (Primary) ; Topotecan (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 12 Nov 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Planned End Date changed from 1 Feb 2019 to 1 Feb 2020.
- 27 Mar 2018 Planned End Date changed from 1 Nov 2018 to 1 Feb 2019.